2009 Canadian Hypertension Education Program recommendations: the scientific summary--an annual update
about
Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertensionEffect of an intervention to improve the cardiovascular health of family members of patients with coronary artery disease: a randomized trial.The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current statusCharacteristics, risk factors, and treatment practices of known adult hypertensive patients in saudi arabia.Hypertension management in patients with renal cell cancer treated with anti-angiogenic agents.Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey2009 Canadian Hypertension Education Program recommendations: an annual update.Beta-adrenergic antagonists in hypertension: a review of the evidence.Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy.Antihypertensive and organ-protective effects of benazepril.Is there benefit in dual renin-angiotensin-aldosterone system blockade? No, yes and maybe: a guide for the perplexed.Blood pressure-lowering efficacy of an olmesartan medoxomil/hydrochlorothiazide-based treatment algorithm in elderly patients (age ≥65 years) stratified by age, sex and race: subgroup analysis of a 12-week, open-label, single-arm, dose-titration stuCompliance to Hypertension Treatment in Residents of a Fishermen Colony in District Kollam, Kerala.Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.Effect of aquatic exercise on mental health, functional autonomy, and oxidative dysfunction in hypertensive adults.
P2860
Q24633649-BE3669DF-1A6C-4AAF-A0D3-ECAAEC063A29Q30562550-62D23277-3246-4BEA-85F2-6BF4EC0B0EFFQ33916677-43C26F6E-C7B4-4F3B-B9C8-6D3734F13605Q34124779-97F8E72F-2769-4515-80B9-FC896911EA7BQ34557378-0584682F-F70A-47DD-8A4D-788A78FC2877Q36136849-9E7E5C8F-27F9-48A3-BE11-7A5B5E6542D0Q36923413-552EC16A-EBCD-4F01-934C-9DFE96ECD168Q37281600-2ECDBFBF-0EE5-41C2-AE48-DA9D05575723Q37637751-25050211-C7DE-4377-AD12-D8A828557223Q37665058-A763DBFF-D079-4168-9D33-E0A2F3869EE3Q37812376-CCC71286-B040-4572-A746-8E87291D18E9Q38076689-F756F291-E470-4400-A4F8-0BE1187D2DE4Q38490084-B8965575-62AA-4431-BEB9-5F51304B30C3Q39970357-30EEFB56-8730-427D-88EA-ABCFB6110E2EQ40932548-E8D7AC3D-4155-431B-BB59-75B65CAFAD1CQ47367584-83D2E1B9-C314-40DD-B39C-4395A5A2CC57
P2860
2009 Canadian Hypertension Education Program recommendations: the scientific summary--an annual update
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
2009 Canadian Hypertension Edu ...... ific summary--an annual update
@en
2009 Canadian Hypertension Edu ...... fic summary--an annual update.
@nl
type
label
2009 Canadian Hypertension Edu ...... ific summary--an annual update
@en
2009 Canadian Hypertension Edu ...... fic summary--an annual update.
@nl
prefLabel
2009 Canadian Hypertension Edu ...... ific summary--an annual update
@en
2009 Canadian Hypertension Edu ...... fic summary--an annual update.
@nl
P2093
P2860
P1476
2009 Canadian Hypertension Edu ...... ific summary--an annual update
@en
P2093
Canadian Hypertension Education Program
Finlay A McAlister
Guy Tremblay
Janusz Kaczorowski
Marcel Lebel
Michael D Hill
Nadia A Khan
Norman R C Campbell
Richard Z Lewanczuk
Sheldon Tobe
P2860
P304
P356
10.1016/S0828-282X(09)70490-8
P577
2009-05-01T00:00:00Z